s.balogun

TL2 · Brno

Contributes reviews on supplier material. Based in Brno.

Joined 28 January 2025 · last posted 4d

73 posts, newest first. Showing up to 150.

Packaging that arrived damaged: documenting it properly Replied, post #48 · Sourcing › Logistics · 24 Jul 2026 · 6 likes Reading rather than contributing, but this is the most useful thread I have found on it.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #56 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 24 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #40 · Compounds › Retatrutide · 20 Jul 2026 · 0 likes Worth separating two things that post #36 runs together. The most useful reply I ever got about glucagon receptor agonist was a request to state my units. It sounds…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #46 · Access › Insurance & coverage · 19 Jul 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
A structured critique template this community uses — a second dataset Replied, post #40 · Evidence › Study critique · 16 Jul 2026 · 25 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
A pooled estimate that changed when one trial was added Replied, post #24 · Evidence › Meta-analyses · 16 Jul 2026 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #55 · Clinical › Comorbidities · 16 Jul 2026 · 11 likes The version of PCOS and metabolic overlap that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Journal club: what we got wrong in an earlier session Replied, post #80 · Evidence › Journal club · 13 Jul 2026 · 5 likes Understood, and I withdraw the assumption I opened with.
Constipation management, with a dietitian's contribution Replied, post #85 · Practice › Side effects · 28 Jun 2026 · 8 likes Narrowing post #84, because the general version has more than one answer. Constipation: common, manageable, and frequently under-reported because it is not dramatic.…
Does dual agonism explain the effect size, or is it dose? Replied, post #37 · Compounds › Tirzepatide · 15 Jun 2026 · 0 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory. I…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #29 · Analytics › Home & field testing · 2 Jun 2026 · 9 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #83 · Practice › Side effects · 21 May 2026 · 3 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Research-use-only status: what it means legally and practically Replied, post #36 · Compounds › Other compounds · 2 May 2026 · 10 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Hair shedding at month three: mechanism and time course — the long version Replied, post #4 · Practice › Side effects · 28 Apr 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #69 · Start Here › Welcome · 22 Apr 2026 · 24 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
[2026 update] Composite endpoints and the component doing the work Replied, post #65 · Evidence › Trials · 11 Apr 2026 · 28 likes What would change my mind on Composite endpoints is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
Foaming during reconstitution and whether it matters — the long version Replied, post #80 · Practice › Reconstitution · 29 Mar 2026 · 2 likes What I want from this Foaming during reconstitution thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can…
Grapefruit: why this class is not the class that cares Replied, post #77 · Practice › Interactions · 25 Mar 2026 · 0 likes Grapefruit came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #108 · Practice › Interactions · 9 Feb 2026 · 0 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #6 · Outcomes › Progress reports · 5 Feb 2026 · 7 likes Distinguishing three things in the Seven-day rolling discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #27 · Research Methods › N-of-1 designs · 1 Feb 2026 · 3 likes Narrowing post #26, because the general version has more than one answer. Designing a personal experiment that could actually change your mind: that is the standard for…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #21 · Compounds › Oral incretins · 7 Jan 2026 · 19 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
What "verified" means on our vendor pages, stated narrowly Replied, post #28 · Sourcing › Vendor reports · 2 Jan 2026 · 12 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Reports of ordinary results are more valuable than reports of remarkable ones,…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #28 · Sourcing › Red flags · 27 Dec 2025 · 11 likes Adding a data point of agreement rather than a data point.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #22 · Access › International · 23 Dec 2025 · 33 likes Post #20 put the caveat in the right place and I want to underline it. Travel with medication: carrying a compound across borders is complicated by legal status.…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #52 · Clinical › Special populations · 14 Dec 2025 · 4 likes This is the answer, and the reason it is the answer is the more useful part.
Tracking a preprint to publication: a worked example Replied, post #71 · Evidence › Preprints · 7 Dec 2025 · 1 like Narrowing post #69, because the general version has more than one answer. The honest position on most preprints in this field is that they are interesting and…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #11 · Sourcing › Independent verification · 2 Dec 2025 · 0 likes Taking post #10 at face value and following it one step further. The practical version of Janoshik is three sentences long. The rigorous version is three pages and…
Tracking a preprint to publication: a worked example Replied, post #5 · Evidence › Preprints · 28 Nov 2025 · 8 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.
Robustness: the parameters worth deliberately varying Replied, post #26 · Analytics › Method validation · 28 Nov 2025 · 1 like Post #25 is the version of this I will quote in future. One addition. System suitability is the ongoing evidence that a validated method is still performing. Validation…
Can a home kit substitute for a laboratory report? A careful no Replied, post #58 · Analytics › Home & field testing · 20 Nov 2025 · 0 likes The confident answers on home kit substitute and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Thyroid function tests during substantial weight change Replied, post #113 · Clinical › Bloodwork · 28 Oct 2025 · 0 likes Liver enzyme changes during rapid weight loss are commonly reported and have several possible explanations, which is exactly why they need clinical interpretation…
Managing an unplanned gap in supply — what changed since Replied, post #100 · Access › Shortages · 28 Oct 2025 · 0 likes Adding the measurement that post #99 says would settle it. Regional differences during a shortage are large, and a supply position in one country says nothing about…
Revisiting: German, French and Dutch differences, compared Replied, post #81 · Regional › European Union · 3 Oct 2025 · 11 likes Post #80 is right about the mechanism and I think understates the practical bit. Distinguishing three things in the German discussion that keep getting used…
Specification in the result column: why that is a meaningful error Replied, post #52 · Analytics › COA interpretation · 2 Oct 2025 · 2 likes The arithmetic in post #49 is right; the assumption feeding it is the part to check. A chromatogram supplied as a small image is legible for peak shape and not for…
Documentation that materially improves an appeal's chances Replied, post #10 · Access › Insurance & coverage · 25 Sep 2025 · 3 likes What would change my mind on documentation is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #9 · Compounds › Semaglutide · 20 Aug 2025 · 0 likes Second this, and I would have said it less carefully.
Asking about a compound your prescriber has not heard of Replied, post #128 · Clinical › Prescriber conversations · 16 Aug 2025 · 11 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring. The strength of…
Revisiting: List price versus negotiated price versus what you pay Replied, post #19 · Access › Pricing · 8 Aug 2025 · 9 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #7 · Clinical › Special populations · 7 Aug 2025 · 26 likes Coming back to post #3, because the follow-up matters more than the original answer. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #47 · Practice › Dosing & titration · 5 Aug 2025 · 1 like Confirming post #45 from a second method, which matters more than confirming it from a second person. Where I would push back on the Escalating every six weeks instead…
Are there stupid questions here? A staff answer, at length Replied, post #4 · Start Here › Welcome · 21 Jul 2025 · 26 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
What this community means by "a source", in practical terms Replied, post #28 · Start Here › Welcome · 8 Jul 2025 · 3 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #12 · Compounds › Semaglutide · 30 Jun 2025 · 32 likes Post #11 answers the question as asked. The question underneath it is different. What would change my mind on semaglutide solutions is a second dataset collected by…
A comparison of home results against a laboratory result on the same vial Replied, post #5 · Analytics › Home & field testing · 13 Jun 2025 · 0 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Specification in the result column: why that is a meaningful error Replied, post #8 · Analytics › COA interpretation · 13 Jun 2025 · 12 likes Worth separating two things that post #6 runs together. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the…
Subcutaneous absorption kinetics and site differences Replied, post #8 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 0 likes Bioavailability for subcutaneous administration in this class is high but not complete, and the published figures are formulation-specific.
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 2 Jun 2025 · 0 likes The opening post is the version of this I will quote in future. One addition. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #11 · Compounds › Secretagogues & GH axis · 31 May 2025 · 17 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #11 · Evidence › Journal club · 21 May 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #33 · Clinical › Comorbidities · 5 May 2025 · 22 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
Follow-up: Documentation that appears only after payment Replied, post #38 · Sourcing › Red flags · 1 May 2025 · 6 likes Narrowing post #35, because the general version has more than one answer. Counterpoint on Documentation, offered without confidence: the same observation is consistent…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #58 · Practice › Reconstitution · 27 Apr 2025 · 0 likes Distinguishing three things in the 5 mg vial discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #42 · Compounds › Retatrutide · 25 Apr 2025 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #68 · Compounds › Tirzepatide · 23 Apr 2025 · 0 likes Confirming post #67 from a second method, which matters more than confirming it from a second person. The titration schedule has more steps than semaglutide's, which…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #59 · Evidence › Journal club · 19 Apr 2025 · 7 likes A session that ends with a list of what remains unresolved is more useful than one that ends with a verdict. The unresolved list is what feeds the next reading.
Retatrutide dose escalation in the published trials Replied, post #143 · Compounds › Retatrutide · 17 Apr 2025 · 25 likes Where I part company with post #141, and it is a narrow parting. On retatrutide dose escalation, I would rather understate and be corrected upward than overstate and be…
Certificates issued by the seller versus by a laboratory Replied, post #15 · Analytics › COA interpretation · 23 Mar 2025 · 27 likes Where I part company with post #14, and it is a narrow parting. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
A newcomer's list of things that confused me, and the fixes Replied, post #7 · Start Here › Welcome · 13 Mar 2025 · 24 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #60 · Compounds › Secretagogues & GH axis · 31 Jan 2025 · 3 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
What changed in 2026, by region Replied, post #99 · Access › International · 25 Jan 2025 · 0 likes I read post #97 twice before replying, because I had assumed the opposite. Where a compound is approved under a different trade name in another market, searching the…
Second pass at: Historical amylin analogues and what happened to them Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 18 Jan 2025 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #15 · Practice › Dosing & titration · 11 Jan 2025 · 24 likes My experience of escalating every six weeks instead contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
Isotonicity and what happens when you get it wrong Replied, post #19 · Pharmacology › Formulation chemistry · 6 Jan 2025 · 22 likes Aggregation is concentration-dependent, which is why reconstituting to a high concentration is not always the convenient choice it appears to be. I would put the burden…
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #9 · Access › Pricing · 31 Dec 2024 · 1 like This follows post #7 rather than contradicting it. Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #81 · Compounds › Tirzepatide · 10 Dec 2024 · 16 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 13 Nov 2024 · 2 likes I disagree with the framing of amylin analogue mechanism above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #17 · Practice › Interactions · 16 Oct 2024 · 16 likes Where the Grapefruit discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Revisiting: How to bring a laboratory report to an appointment usefully Started this topic · Clinical › Bloodwork · 29 Aug 2024 · 41 likes Revisiting: How to bring a laboratory report to an appointment usefully — setting out what I have, and where I think it stops being reliable. Asking about bring a…
Promotion criteria, and the one that stops most nominations Replied, post #42 · Documentation › Doc review · 20 Aug 2024 · 25 likes The arithmetic in post #41 is right; the assumption feeding it is the part to check. The four criteria are that the question recurs, that the content is correct and…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #33 · Safety › Contraindications · 26 Jul 2024 · 9 likes No disagreement from me. Posting only so the question does not look ignored.
Pen wastage and its effect on real cost Replied, post #9 · Access › Pricing · 20 Jul 2024 · 32 likes Where I part company with post #5, and it is a narrow parting. Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing…
Cold packs, phase-change material, and what survives ten days Replied, post #116 · Sourcing › Logistics · 17 Jul 2024 · 9 likes Narrowing post #115, because the general version has more than one answer. The most useful reply I ever got about cold packs was a request to state my units. It sounds…